Podcasts about juvenescence investing

My guest Jim Mellon is an accomplished investor, entrepreneur, author and philanthropist. His most recent book called "Moo's Law" focuses on the investment opportunities in the field of cellular agriculture, which is a production of proteins and materials directly from stem cells.  Jim Mellon co-founded Agronomics to invest in a portfolio of leading companies in this sector, as he is its largest investor. In this conversation, we dig into this new area, we talk about the case for change, the challenges and opportunities, some of the people, and some of the nations that are driving and supporting these forward thinking cell-ag companies. What We Cover:  - How Jim developed his interest in biotech, longevity and cellular agriculture - Why industrial agriculture needs to change and what cell-ag offers to the world - The concepts of Moo's Law and griddle parity  - Which different categories of industry cellular agriculture are disrupting and revolutionising - The current state of cell-ag markets and products, and why Middle Eastern countries are faster to adopt this new industry - What challenges are facing the ramp up of cell-ag - The attractive characteristics of cell-ag companies for investors  - When we can expect cell-ag meat and fish to enter the European and US markets on larger scale Key Learnings and Takeaways:  - Moo's law suggests that as scale increases in the manufacture of foods in laboratory conditions, the efficiency will go up and the price will come down - Food-insecure countries such as Middle Eastern countries which import most of their food, will provide a model for implementing cell-ag for larger markets, such as the UK, EU and USA - The challenges facing cell-ag industry are performance of the stem cell lines on massive scale, using animals to continually provide more stem cells, and the execution of startup companies in this field   Links and Resources Mentioned in This Episode:  - Agronomics https://agronomics.im/  - Juvenescence https://www.juvlabs.com/  - ‘Moo's Law: An Investor's Guide to the New Agrarian Revolution' by Jim Mellon https://mooslawbook.com/  - 'Juvenescence: Investing in the Age of Longevity' by Jim Mellon https://www.amazon.com/Juvenescence-Investing-longevity-Mellon-Jim/dp/0993047815/  - 'Cracking the Code: Understand and Profit from the Biotech Revolution That Will Transform Our Lives and Generate Fortunes' by Jim Mellon https://www.amazon.com/Jim-Mellon/dp/1119963184/  - Blue Nalu https://www.bluenalu.com/  - Ivy Farm Technologies https://www.ivy.farm/  - Mohnish Pabrai: Cloning, Learning from Charlie Munger, 100 Baggers on OutsideVoices https://outsidelens.com/mohnish-pabrai-cloning/ - Joel Greenblatt: The Common Sense of Long-Term Investing on OutsideVoices https://outsidelens.com/joel-greenblatt-the-common-sense-of-long-term-investing/ Connect with Mark Bidwell: - LinkedIn https://www.linkedin.com/in/markbidwell/  - Twitter https://twitter.com/markehb

Olivier Roland vous partage un extrait du livre “Juvenescence : Investing in the Age of Longevity” qui insiste sur l’importance de l’éducation et qu’elle sera le passport clé pour la prospérité. Découvrez-le dans ce podcast ! Ressources : Le livre ... Read More » L’article Ce que ce MILLIARDAIRE a à dire sur l’éducation en ligne et son futur (152/365) est apparu en premier sur Olivier Roland Radio.

This week's guest is Jim Mellon, billionaire investor, speaker, and co-author of Juvenescence: Investing in the Age of Longevity. We discuss: * His 2005 book that predicted the oncoming storm of the GFC * The coming bear market in tech stocks and why he's short Facebook * The new developments in the treatment of cancer, heart disease, lung disease, and diabetes that could significantly improve survivability * The changes in lifestyle that are already extending our lifespans Medications that could dramatically extend lifespans and healthspans * The winners, losers, and economic effects of longer lives

In today's show, I'll dive into the third part of a series on investing with paid research, using a book called Juvenescence by Al Chalabi and Jim Mellon. These guys have their own investment company, do all the research, and we get to benefit. They don't make lots of money on the books, it's literally the research. The book is all about researching ways of living forever, or extending the human life. In today's show, I'll talk about four companies in the space that specialize in Gene Editing technology, mentioned in the book to provide an idea of the research. SGMO, EDIT, CRSP, BLUE If you have any feedback, please send an email to alex.richwagen@gmail.com Thanks! Alex Link to book -https://www.amazon.com/Juvenescence-Investing-longevity-Mellon-Jim/dp/0993047815/ref=sr_1_1?ie=UTF8&qid=1521077298&sr=8-1&keywords=juvenescence+investing+in+the+age+of+longevity

Welcome to the 43rd CONKERS’ CORNER recorded on 25th March 2017 at the Master Investor Show in Islington. In this interview I have the pleasure of speaking to Jim Mellon @jimmhk the renowned serial entrepreneur, self-made multi-millionaire investor, best selling author and the owner of the Master Investor Show. As one of Britain’s richest individuals with his wealth estimated to be exceeding £900 million, Jim has been described as our very own Warren Buffett. The son of a diplomat, he read Philosophy, Politics and Economics (PPE) at Oxford University, where he attained his Master’s Degree. However unlike many of his peers, he chose not go into the world of politics as he had travelled widely whilst he was young and had always intended to travel as soon he finished his studies. He was offered six jobs and chose to begin his career as a trainee Fund Manager with GT Management (now owned by Invesco) in Hong Kong. He has readily admitted that at the time, “I only had a vague idea of the workings of shares and bonds”. Jim made a great success of his time with GT Management, however when he was around 24 years of age his first boss and mentor at GT, Richard Thornton left the business. They sent about setting up their own Fund Management business and co-founded Thornton Management. By the time Jim was 28 years of age he was millionaire. After more than six years with Thornton, Jim set up his own business in 1991, now known as Charlemagne Capital and Regent Pacific. Alongside these businesses, he also has a private investment company, the Burnbrae Group, which makes up most of his vast investment endeavours, all of which have made him a potential future self made investor billionaire. Jim has also co-written several best selling books with Al Chalabi which you can find here http://www.burnbrae.com/books . Their new book “Juvenescence: Investing in the Age of longevity” will be released next month, and you can pre-order a copy now at https://www.juvenescence-book.com/ . For those that are intrigued by the title of the book, Juvenescence means “the state or period of being young”. The book discusses the benefits of a healthy life; what is good and detrimental for us and the breakthrough technologies that will enable all of us to live longer, as well as potentially invest in. In the discussion and video with Jim, he provides an insight into the journey that he has taken, which so far has encompassed Fund Management, Investing, Emerging Markets, Asia, Russia, America, Technology, Healthcare, being an Author, Private Investor and much much more. The topics we discussed include: Making informed decisions; Educational philanthropy; Pensions; Financial risks; Investing Strategy; Investment lessons learned; Russian Mafia; His life at risk; Master Investor Show; “Curiosity, Adaptability & Application”; No easy route to riches; Investing; Collaboration of information; Sharing of information; His new book : ‘Juvenescence’; Risks; Longevity. He has experienced several financial crashes and also turned around Regent Pacific from the brink of collapse after the Russian financial crisis. Jim stresses, “Like everyone, I have made a tremendous amount of mistakes”. Listen now to gain insights into how Jim Mellon selects, researches and filters his investments in order to find the best cutting edge long-term potential opportunities for his investing empire. Learn from the lessons in his successful, insightful investing journey and the thought provoking knowledge from his many investing books.

"You're going to live till you're 120 years old". That's what my guest today on Stuff That Interests Me thinks, one of Britain's most successful investors, Jim Mellon. Jim explains why - a combination of new drugs, technologies and lifestyles. What are you going to do with all your time? The next great investment trend will be around the fact that we are all going to love a lot longer. Find out more in the this fascinating interview. Juvenescence - Investing in the Age of Longevity is available from all good bookstores and at https://www.juvenescence-book.com/ See acast.com/privacy for privacy and opt-out information.

"You're going to live till you're 120 years old". That's what my guest today on Stuff That Interests Me thinks, one of Britain's most successful investors, Jim Mellon.Jim explains why - a combination of new drugs, technologies and lifestyles. What are you going to do with all your time?The next great investment trend will be around the fact that we are all going to love a lot longer. Find out more in the this fascinating interview.Juvenescence - Investing in the Age of Longevity is available from all good bookstores and at https://www.juvenescence-book.com/ See acast.com/privacy for privacy and opt-out information. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit frisby.substack.com/subscribe